Patents by Inventor Geoff Cole

Geoff Cole has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods And Compositions For Prevention Or Treatment Of RSV Infection Using Modified Duplex RNA Molecules
    Publication number: 20150337311
    Abstract: Methods and compositions are provided for the prevention or treatment of RSV infection in a human. The methods include administering one or more doses of a composition comprising an siRNA. The dose can be formulated for topical or parenteral administration. Topical administration includes administration as a nasal spray, or by inhalation of respirable particles or droplets. The siRNA preferably comprises a sense strand and antisense strand with modified nucleotides.
    Type: Application
    Filed: February 17, 2015
    Publication date: November 26, 2015
    Inventors: Rachel Meyers, Rene Alvarez, Geoff Cole, Sayda Elbashir
  • Methods And Compositions For Prevention Or Treatment Of RSV Infection Using Modified Duplex RNA Molecules
    Publication number: 20140323541
    Abstract: Methods and compositions are provided for the prevention or treatment of RSV infection in a human. The methods include administering one or more doses of a composition comprising an siRNA. The dose can be formulated for topical or parenteral administration. Topical administration includes administration as a nasal spray, or by inhalation of respirable particles or droplets. The siRNA preferably comprises a sense strand and antisense strand with modified nucleotides.
    Type: Application
    Filed: September 5, 2012
    Publication date: October 30, 2014
    Inventors: Rachel Meyers, Rene Alvarez, Geoff Cole, Sayda Elbashir
  • Methods and Compositions for Prevention or Treatment of RSV Infection Using Modified Duplex RNA Molecules
    Publication number: 20100168205
    Abstract: Methods and compositions are provided for the prevention or treatment of RSV infection in a human. The methods include administering one or more doses of a composition comprising an siRNA. The dose can be formulated for topical or parenteral administration. Topical administration includes administration as a nasal spray, or by inhalation of respirable particles or droplets. The siRNA preferably comprises a sense strand and antisense strand with modified nucleotides.
    Type: Application
    Filed: October 23, 2009
    Publication date: July 1, 2010
    Applicant: ALNYLAM PHARMACEUTICALS, INC.
    Inventors: Rachel Meyers, Rene Alvarez, Geoff Cole, Sayda Elbashir